U.S. DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

U.S. Dental Membrane and Bone Graft Substitutes Market Size Analysis - 2026 To 2033

The U.S. Dental Membrane and Bone Graft Substitutes Market size is anticipated to grow at a CAGR of 8.6% with USD 550 Mn in 2026 and is expected to reach USD 980 Mn in 2033. The market is growing with the rising dental implant procedures, increasing periodontal disease burden, growing use of guided bone regeneration, and higher demand for socket preservation and ridge augmentation. According to the CDC, nearly 42% of U.S. adults aged 30 years and older have periodontitis, while severe periodontitis affects about 8% of adults, supporting continued demand for bone regeneration solutions.

Key Takeaways

• The bone graft substitutes segment is projected to account for the largest share of 62.4% in 2026. The segment growth is due to the rising implant procedures and the need to restore jawbone volume before implant placement. Dental bone grafting is required in up to 50% of implant procedures, propelling the growth in the segment.
• The collagen segment is projected to account for the largest share of 32.5% in 2026. The segment’s growth is attributable to its wide use in resorbable membranes, biocompatibility, and strong role in guided bone regeneration procedures for periodontal and implant-related defects.
• The socket preservation segment is projected to secure the largest share of 28.6% in 2026. The segment’s growth is owing to the growing tooth extraction cases and the need to preserve alveolar bone for future dental implants. Around 12.9% of older U.S. adults (65+) are fully edentulous, indicating high post-extraction reconstruction need.
• The dental clinics segment is expected to occupy the highest share of 52.3% in 2026. The segment’s growth is due to the increasing volume of outpatient dental procedures, socket preservation, and dental implant surgeries performed in these settings. Nearly 60% of U.S. adults aged 65 years had a periodontal disease.

Segmental Insights 

Which Bone Graft Substitutes Segment Dominates the Market?

On the basis of product type, the bone graft substitutes segment accounts for the largest U.S. Dental Membrane and Bone Graft Substitutes Market share of 62.4% in 2026. The growth of the segment is mainly driven by the strong clinical need to rebuild alveolar bone after tooth extraction, periodontitis, and implant-site preparation.

In addition, the NIDCR reported that the U.S. seniors aged 65 years and older had an average of 21 remaining teeth, while about 15% had no remaining natural teeth. This highlights the need for ridge preservation and implant-related reconstruction.

In February 2025, LifeNet Health launched OraGen, the first viable dental bone allograft using cryopreserved corticocancellous bone with osteogenic, osteoconductive and osteoinductive properties. The product is available in the U.S. through Salvin Dental Specialties and is used in sinus and ridge augmentation procedures.

Collagen Segment to Secure the Largest Share 

On the basis of material, the collagen segment accounts for the largest U.S. Dental Membrane and Bone Graft Substitutes Market share of 32.5% in 2026. The segment’s growth is owing to the fact that they are resorbable, biocompatible, and suitable for guided bone regeneration and guided tissue regeneration.

ClinicalTrials.gov also listed a May 2026 study evaluating whether adding a resorbable collagen membrane to an anorganic bone-collagen composite graft improves ridge preservation, showing active clinical interest in collagen membrane use.

In February 2024, BioHorizons Camlog launched Striate+, a collagen membrane developed by Orthocell for guided bone and tissue regeneration. The porcine-derived, biocompatible membrane supports implant dentistry through handling, bilayer osteoconductive design, and physiological resorption within 26 weeks, reducing reintervention needs.

Socket Preservation to Dominate with the Major Share

On the basis of application, the socket preservation segment is projected to secure the largest share of 28.6% in 2026. The segment’s growth is owing to the high clinical need to maintain alveolar ridge volume immediately after tooth extraction, supporting future implant placement and restorative dentistry.

U.S. disease burden continues to create a steady pool of extraction-risk patients. CDC’s 2024 Oral Health Surveillance Report reported untreated decay in permanent teeth among 20.5% of dentate adults aged 20–64.

In March 2026, FDA granted 510(k) substantial-equivalence clearance to Hudens Bio’s BONTREE PLUS, a synthetic HA/OCP bone graft material indicated for extraction sites, ridge augmentation, sinus lifts, and periodontal defects in the commercial U.S. market.

Why Dental Clinics are Leading the U.S. Market

On the basis of end user, the dental clinics segment is expected to occupy the highest share of 52.3% in 2026. The segment’s growth is due to their central role in implant placement, socket preservation, ridge augmentation, and guided bone regeneration procedures.

Clinics benefit from high patient flow for routine and surgical dentistry. The CDC reported that 65.5% of U.S. adults had a dental exam or cleaning in the past year in 2023.

Market Drivers

Rising Innovations in Collagen Membranes are Transforming the U.S. Dental Membrane and Bone Graft Substitutes Market

The U.S. market is seeing strong innovation in collagen-based dental membranes, particularly in handling strength, hydrated stability, tensile resistance, and adaptation to ridge contour. These features are important because regenerative dental procedures require barrier membranes to maintain space, prevent soft tissue ingrowth, and support the bone formation during guided bone regeneration.

Dentsply Sirona’s regenerative portfolio, for example includes bone graft materials, resorbable and non-resorbable membranes, and instruments under its Symbios line, thereby reflecting the shift toward integrated regenerative workflows.

In October 2025, Geistlich launched Geistlich Bio-Gide Forte, an advanced resorbable collagen membrane based on proven Bio-Gide technology, in North America. Such product upgrades are expected to increase the adoption of premium collagen membranes in hospitals, oral surgery centers, as well as dental implant practices.

Next-Generation Biomaterials: A Major Breakthrough in U.S. Dental Membrane and Bone Graft Substitutes Market

Next-generation biomaterials are reshaping the Dental Membrane and Bone Graft Substitutes Market by improving socket preservation, guided bone regeneration, and implant-site preparation with resorbable, osteoconductive, and membrane-supported materials.

The regulatory activity also supports biomaterial innovation. In February 2025, FDA determined Shenzhen Dazhou Medical Technology’s Synthetic Bone Graft Particulate substantially equivalent under 510(k). The device is a sterile, absorbable 45S5 bioactive-glass particulate, sized 0.5–1 mm. It is intended to augment alveolar bone in tooth-extraction sockets and progressively resorb as new bone forms.

This speeds up the adoption of cutting edge synthetic alternatives across dental clinics as well as hospitals for the U.S. commercial use.

Current Events and Their Impact on the U.S. Dental Membrane and Bone Graft Substitutes Market (regulatory shifts, government policies)

U.S. Dental Membrane and Bone Graft Substitutes Market Trends

• Rising demand for implant-based dental restoration increases the use of bone graft substitutes and membranes for socket preservation, ridge augmentation, sinus lifts, and guided bone regeneration.
• Growing preference for resorbable collagen membranes improves healing, reduces need for second surgical removal, and supports broader adoption across dental clinics.
• Digital dentistry, CBCT imaging, and guided implant planning improve graft placement accuracy, treatment predictability, and patient-specific regenerative procedures.
• High burden of periodontal disease and tooth loss strengthens demand for regenerative dental procedures. CDC data shows about 4 in 10 U.S. adults aged 30 years or older had some level of periodontitis. Tooth loss remains common among seniors, with 11% of adults aged 65–74 and 20% aged 75+ having lost all teeth.
• Expanding dental insurance coverage and medically necessary dental coverage discussions support access to oral rehabilitation. However, Original Medicare generally excludes routine dental implants. CMS allows coverage only when dental services are linked to covered medical procedures, making private insurance and Medicare Advantage important access channels.

Who are the Major Companies in U.S. Dental Membrane and Bone Graft Substitutes Market

Some of the major key players in U.S. Dental Membrane and Bone Graft Substitutes Market are Institut Straumann AG, Nobel Biocare Services AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., BioHorizons, Inc., NovaBone Products, LLC, Collagen Matrix, Inc., Maxigen Biotech, Inc., Osteogenics Biomedical, Medtronic, OUSIA

Key News

• In May 2026, CGBio entered a commercialization and clinical development agreement with DePuy Synthes for its Novosis bone graft substitute portfolio in the U.S., Canada, and Australia.
• In September 2024, Regenity Biosciences received NMPA approval in China for its Matrixflex crosslinked collagen dental membrane. A clinical trial in 174 patients showed improved periodontal outcomes compared to Geistlich Bio-Gide. The product is intended for guided bone and tissue regeneration procedures.

Market Report Scope 

Analyst Opinion

• The U.S. dental membrane and bone graft substitutes market is driven by real clinical need, mainly tooth loss, gum disease, and implant preparation. More than 178 million Americans are missing at least one tooth, while tooth loss and periodontal complications remain a leading cause of alveolar bone resorption requiring grafting and membrane-based regenerative procedures.
• Tooth loss remains a major demand base for regenerative dental procedures. In the U.S., 26% of adults aged 65+ have 8 or fewer teeth, and more than 15% have lost all teeth, supporting demand for grafting, ridge preservation, and implant-related bone regeneration.
• Dental implants are a key growth engine for membranes and bone graft substitutes. Around 3 million people in the U.S. have dental implants, increasing by about 500,000 annually. The clinical literature also estimates that up to 50% of dental implant procedures involve bone grafts, directly supporting graft substitute and membrane usage.

Market Segmentation

• By Product Type (Revenue, USD Mn, 2021-2033)
  • Dental Membrane
    • Resorbable Membranes
    • Non-resorbable Membranes
  • Bone Graft Substitutes
    • Demineralized Bone Matrix (DBM)
    • Allograft
    • Xenograft
    • Synthetic Bone Graft Substitute
• By Material (Revenue, USD Mn, 2021-2033)
  • Collagen
  • Hydrogel
  • Hydroxyapatite (HA)
  • Tricalcium Phosphate (TCP)
  • Polytetrafluoroethylene
  • Human Cells Source
  • Others
• By Application (Revenue, USD Mn, 2021-2033)
  • Socket Preservation
  • Ridge Augmentation
  • Sinus Lifts
  • Guided Bone Regeneration (GBR)
  • Guided Tissue Regeneration (GTR)
• By End User (Revenue, USD Mn, 2021-2033)
  • Hospitals
  • Dental Clinics
  • Others

Sources

Primary Research Interviews

• Periodontists
• Oral and maxillofacial surgeons
• Dental implantologists and prosthodontists
• Dental clinic and hospital dental department administrators
• Dental biomaterial and implant product distributors
• Key opinion leaders (KOLs) in regenerative dentistry and periodontology

Databases

• World Health Organization (WHO)
• Centers for Disease Control and Prevention (CDC)
• National Institutes of Health (NIH) / National Institute of Dental and Craniofacial Research (NIDCR)
• Organisation for Economic Co-operation and Development (OECD)

Magazines

• Dentistry Today
• Dental Economics
• Inside Dentistry

Journals

• Journal of Periodontology
• Clinical Oral Implants Research
• The International Journal of Oral & Maxillofacial Implants
• Journal of Oral and Maxillofacial Surgery

Newspapers

• The New York Times
• The Wall Street Journal
• USA Today

Associations

• American Dental Association (ADA)
• American Academy of Periodontology (AAP)
• Academy of Osseointegration (AO)
• American Association of Oral and Maxillofacial Surgeons (AAOMS)
• Public Domain Sources
• Company Annual Reports and Investor Presentations
• U.S. Food and Drug Administration (FDA) Databases, including 510(k), PMA, and MAUDE
• Clinical Trial Registries such as ClinicalTrials.gov

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of Information for the Last 10 Years